Literature DB >> 11674148

Solid-Phase Synthesis of Tyrosine Peptide Aldehydes. Analogues of (S)-MAPI.

Patrick Page1, Mark Bradley, Iain Walters, Simon Teague.   

Abstract

We report an efficient solid-phase synthesis of C-terminal tyrosine peptide aldehydes based on the HIV protease inhibitors (S)-MAPI and GE 20372 A. Our strategy consisted of anchoring the side chain of Dde-Tyrosinol (5) onto the brominated Wang linker derivative ((4-bromomethyl)-phenoxy-allyl acetate) (6) to give after ester hydrolysis the N(alpha)-(Dde)-O-(4-methylphenoxyacetic acid)-L-Tyrosinol template (8). This was attached to aminomethyl resin and elongated using standard Fmoc protocols. Importantly there was no evidence of esterification side reactions. The unsymmetrically substituted urea linkage of the (S)-MAPI family was incorporated using the N(alpha)-(4-nitrophenyloxycarbonyl)amino acid tert-butyl esters following which the protected tetrapeptide alcohol immobilized on the solid support was oxidized to its corresponding aldehyde using sulfur trioxide-pyridine. The efficiency and reliability of the oxidation step was dramatically improved by the incorporation of a small PEG-spacer between the linker and the solid support. The tetrapeptides 12a and 12b were cleaved by acidolysis, purified by RP HPLC, and isolated in high yield and purity, demonstrating the success of the whole synthetic process.

Entities:  

Year:  1999        PMID: 11674148     DOI: 10.1021/jo981546v

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Design and synthesis of a dual linker for solid phase synthesis of oleanolic acid derivatives.

Authors:  Shaorong Wang; Weishuo Fang
Journal:  Molecules       Date:  2011-06-08       Impact factor: 4.411

2.  Solid-phase synthesis and screening of a library of C-terminal arginine peptide aldehydes against Murray Valley encephalitis virus protease.

Authors:  Nicholas J Ede; Jeffrey Hill; Joma K Joy; Anne-Marie Ede; Merran L Koppens
Journal:  J Pept Sci       Date:  2012-09-18       Impact factor: 1.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.